1-3 of 3
Craig R Nichols, MD
Close
Sort by
Journal Articles

A Placebo-Controlled Phase III Trial of Patient-Specific Immunotherapy with Mitumprotimut-T (ID-KLH) and GM-CSF Following Rituximab in Patients with CD20+ Follicular Lymphoma

Arnold S. Freedman, MD, Sattva Neelapu, MD, Craig R Nichols, MD, Michael Robertson, MD, Benjamin Djulbegovic, MD, PhD, Jane N. Winter, MD, Daniel Gold, PhD, John Bender, PharmD, Morgan Stewart, PhD, Richard G. Ghalie, MD, MBA, Paul A. Hamlin, Jr., MD
Journal: Blood
Blood (2008) 112 (11): 236.
https://doi.org/10.1182/blood.V112.11.236.236
Published: 2008
Journal Articles

Survival after Autologous Transplantation to Treat Diffuse Large B-Cell Lymphoma with a History of CNS Involvement, Bone Marrow Involvement, or Histologic Transformation.

Brandon Hayes-Lattin, MD, Pritesh Mehta, Adam Dunn, Nan Subbiah, Jose F. Leis, MD, PhD, Aleksandra Simic, MD, Bryon Allen, Suzanne Balliesen, Peter T. Curtin, MD, Elliot Epner, MD, PhD, William H. Fleming, MD, PhD, Carol Jacoby, Michael J. Mauro, MD, Craig R. Nichols, MD, Susan Schubach, Richard T. Maziarz, MD
Journal: Blood
Blood (2004) 104 (11): 5237.
https://doi.org/10.1182/blood.V104.11.5237.5237
Published: 2004
Journal Articles

Cyclin D1 Deregulation in Mantle Cell Lymphoma: Tethering of the Cyclin D1 Promoter and 3′ Immunoglobin Enhancers by CTCF and Nucleophosmin.

Elliot M. Epner, MD PhD, Hui Liu, PhD, Wang Jin, PhD, Jing Huang, PhD, Craig R. Nichols, MD, Richard T. Maziarz, MD
Journal: Blood
Blood (2004) 104 (11): 1536.
https://doi.org/10.1182/blood.V104.11.1536.1536
Published: 2004